sb 203580 has been researched along with Peritonitis in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Wu, H; Zhang, L; Zhang, Z; Zhou, C | 1 |
Fukuda, Y; Goto, M; Terakawa, M; Tomimori, Y | 1 |
2 other study(ies) available for sb 203580 and Peritonitis
Article | Year |
---|---|
Ketamine inhibits LPS-induced HGMB1 release in vitro and in vivo.
Topics: Animals; Cecum; Cell Line; Disease Models, Animal; HMGB1 Protein; Humans; Imidazoles; Ketamine; Lipopolysaccharides; Macrophages; Male; Mice; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Peritonitis; Pyridines; Rats; Rats, Sprague-Dawley; Sepsis | 2014 |
Mast cell chymase induces expression of chemokines for neutrophils in eosinophilic EoL-1 cells and mouse peritonitis eosinophils.
Topics: Animals; Butadienes; Cell Line, Tumor; Chemokine CXCL2; Chemokines; Chymases; Cytokines; Dose-Response Relationship, Drug; Enzyme Inhibitors; Eosinophils; Gene Expression; Humans; Imidazoles; Interleukin-8; Mice; Mice, Inbred BALB C; Mitogen-Activated Protein Kinases; Neutrophils; Nitriles; Peritonitis; Pertussis Toxin; Pyridines; Quinazolines; RNA, Messenger; Serine Endopeptidases | 2006 |